An analysis of the Framingham Heart Study data found that higher epigenetic aging metrics predicted lower scores on the ...
The Brighterside of News on MSN
New study provides a key breakthrough in cancer therapy and synthetic biology
Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics. Even cells with the same DNA can act differently because their molecules ...
Angiosperms, also known as flowering plants, represent the most diverse group of seed plants, and their origin and evolution ...
A five-year study suggests gene therapy may help reduce bleeding and infusions as a hemophilia B treatment option.
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate ...
The firm submitted non-clinical and clinical modules of its rolling BLA for DTX401 in August and has now submitted the chemistry, manufacturing, and controls module.
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
A recent study finds that certain psychiatric disorders have considerable genetic overlap. But these genes aren’t the whole ...
Research shows hair follicle aging begins in your 30s, driven by inflammation-linked gene activity detectable years before ...
Plastic is a durable tough material that has been adopted for use in countless products. That widespread use has also led to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback